Charles River (CRL) Laboratories and BioTech Social announced the exploration of a potential client-centric collaboration to enable Charles River Incubator and Accelerator Program participants to access the BioTech Funding Portal. If formalized, the partnership would allow early-stage cell and gene therapy developers to raise up to $5M per year via the platform. The BioTech Funding Portal exclusively lists life sciences companies, acting as a conduit for crowdfunding.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRL: